Artelo biosciences appoints finance and healthcare industry executive tamara a. seymour to board of directors

La jolla, calif., march 09, 2021 (globe newswire) -- artelo biosciences, inc. (nasdaq: artl ), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system, today announced the appointment of tamara a. seymour, cpa, to the company's board of directors.
ARTL Ratings Summary
ARTL Quant Ranking